ArticlePharmacology research & perspectives2020

Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non-small cell lung cancer (NSCLC) in Europe.

Kui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.